Clinical trials
Phase 1 Papillomavirus Infections trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Terminated | 3 |
| Unknown status | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Antiva Biosciences | 2 |
| BlueSky Immunotherapies GmbH | 2 |
| Shanghai Bovax Biotechnology Co., Ltd. | 2 |
| 2A Pharma AB | 1 |
| AIDS Malignancy Consortium | 1 |
| Beijing Health Guard Biotechnology, Inc | 1 |
| Cancer Research UK | 1 |
| Gilead Sciences | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Papillomavirus Infections | 25 |
| Uterine Cervical Neoplasms | 8 |
| Anus Neoplasms | 3 |
| Condylomata Acuminata | 3 |
| HIV Infections | 3 |
| Precancerous Conditions | 2 |
| Squamous Intraepithelial Lesions | 2 |
| Uterine Cervical Dysplasia | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 51 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.